Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma

<div>(a) Expression of podoplanin in OSCC: weak reactivity (&gt;10% tumor cells positive and weak staining). (b) Expression of podoplanin in OSCC: moderate reactivity (10–30% tumor cells positive and moderate staining). (c) Expression of podoplanin in OSCC: high reactivity (50–80% tumor cells positive and strong staining).</div>

Scientifica

fig4

Figure 4

Figure 4: Evaluation of Podoplanin in Oral Leukoplakia and Oral Squamous Cell Carcinoma 